• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hypertension in primary glomerulonephritis without renal insufficiency.

作者信息

Zucchelli P, Zuccalà A, Mancini E

机构信息

Divisione di Nefrologia e Dialisi, Policlinico S. Orsola-Malpighi, Bologna, Italy.

出版信息

Nephrol Dial Transplant. 1989;4(7):605-10.

PMID:2510057
Abstract

Hypertension is frequently present in glomerulonephritis without renal insufficiency but its pathogenesis is poorly understood. Eighty-five patients with glomerulonephritis and normal renal function, including 55 hypertensive patients, and 24 normal subjects were studied to obtain data on the mechanisms responsible for hypertension. Plasma renin activity (PRA), plasma noradrenaline, total exchangeable sodium, and urinary prostaglandin E (PGE) were determined. Moreover, the autonomic nervous system was explored with the following tests: tilt test, diving reflex, lying down, and deep-breathing tests. In 15 of the 30 normotensive patients with glomerulonephritis, PRA was measured after the administration of propranolol and then indomethacin. No significant differences were found in the mean values of PRA, plasma noradrenaline, total exchangeable sodium, urinary PGE, and autonomic nervous system behaviour between glomerulonephritis patients with and without hypertension or between hypertensive glomerulonephritis patients and control subjects. In many of the normotensive glomerulonephritis patients we found an elevated PRA that was normalised by propranolol but not by indomethacin. In summary, hypertension in glomerulonephritis is not associated with abnormalities in the sodium balance, with renin-angiotensin or with autonomic nervous system abnormalities. A renin hypersecretion seems to be present only in some normotensive patients with glomerulonephritis.

摘要

相似文献

1
Hypertension in primary glomerulonephritis without renal insufficiency.
Nephrol Dial Transplant. 1989;4(7):605-10.
2
The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.慢性肾小球肾炎所致终末期肾病高血压患者血浆肾素活性控制受损。
Clin Nephrol. 1994 Nov;42(5):300-8.
3
Catecholamines, sodium and renin in unilateral renal hypertension in man.人体单侧肾性高血压中的儿茶酚胺、钠和肾素
Miner Electrolyte Metab. 1982 Feb;7(2):97-112.
4
Hypertension in end-stage renal failure: role of sympathetic nervous system, sodium balance and renal pressor system.
Life Support Syst. 1983 Apr-Jun;1(2):101-11.
5
[Correlations between heart rate variability, renin activity and plasma aldosteron concentration in chronic glomerulonephritis with intact function of the kidneys].
Ter Arkh. 2009;81(8):20-3.
6
[The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].[卡托普利试验——有助于检测瘢痕性肾病作为儿童动脉高血压的病因]
Srp Arh Celok Lek. 1999 Sep-Oct;127(9-10):305-11.
7
Hypertension in end-stage renal disease. The relationship between blood pressure, plasma renin, plasma renin substrate and exchangeable sodium in chronic hemodialysis patients.终末期肾病中的高血压。慢性血液透析患者的血压、血浆肾素、血浆肾素底物与可交换钠之间的关系。
Acta Med Scand. 1976;200(4):257-61.
8
Plasma renin activity (PRA) and aldosterone (PA) in patients with chronic glomerulonephritis (GN) and hypertension.慢性肾小球肾炎(GN)合并高血压患者的血浆肾素活性(PRA)和醛固酮(PA)
Clin Nephrol. 1976 Feb;5(2):57-60.
9
Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems.
Miner Electrolyte Metab. 1995;21(1-3):77-81.
10
[Arterial hypertension in patients on chronic hemodialysis].[慢性血液透析患者的动脉高血压]
Srp Arh Celok Lek. 1996 Sep-Oct;124(9-10):246-50.

引用本文的文献

1
Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation.与活性氧和血压调节相关的遗传多态性。
Pharmacogenomics J. 2019 Aug;19(4):315-336. doi: 10.1038/s41397-019-0082-4. Epub 2019 Feb 6.